Winslow Evans & Crocker’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-481
Closed -$22K 1136
2020
Q2
$22K Hold
481
0.01% 599
2020
Q1
$22K Sell
481
-2,722
-85% -$106K 0.01% 564
2019
Q4
$116K Hold
3,203
0.03% 377
2019
Q3
$112K Hold
3,203
0.03% 377
2019
Q2
$138K Sell
3,203
-18
-0.6% -$746 0.04% 337
2019
Q1
$140K Buy
3,221
+18
+0.6% +$724 0.04% 327
2018
Q4
$118K Hold
3,203
0.04% 332
2018
Q3
$130K Hold
3,203
0.04% 328
2018
Q2
$124K Hold
3,203
0.04% 331
2018
Q1
$110K Hold
3,203
0.04% 341
2017
Q4
$105K Hold
3,203
0.03% 357
2017
Q3
$107K Sell
3,203
-3,538
-52% -$122K 0.04% 352
2017
Q2
$226K Buy
6,741
+5,443
+419% +$184K 0.06% 297
2017
Q1
$40K Buy
+1,298
New +$40K 0.01% 581

Other funds holding QGEN

Winslow Evans & Crocker's QGEN Position: Q3 2020 in Review

Winslow Evans & Crocker sold out of Qiagen (QGEN) in Q3 2020, closing a stake of 481 shares — an estimated $22K sold.

Winslow Evans & Crocker first reported a position in QGEN in Q1 2017 and held it in 14 quarters. The position peaked at $226K in Q2 2017. 252 funds tracked by Wall St. Rank hold QGEN as of Q3 2020.

  • Winslow Evans & Crocker reported no remaining Qiagen position as of Q3 2020 after selling out during the quarter.
  • Winslow Evans & Crocker sold 481 Qiagen shares in Q3 2020, an estimated $22K.
  • Winslow Evans & Crocker first reported a position in Qiagen in Q1 2017 and held it in 14 quarters.
  • Winslow Evans & Crocker's Qiagen position peaked at $226K in Q2 2017.
  • 252 funds tracked by Wall St. Rank held Qiagen as of Q3 2020.

Based on Winslow Evans & Crocker's 13F filing for Q3 2020, filed 21 Oct 2020.